first day of semaglutide How long does it take for the Wegovy pill to start working? Tips and Tricks While on

Source: Evaluate Pharma, World Obesity Federation, Putnam Analysis Q2, 2025 Unmet Needs and Potential Differentiation Levers Despite extraordinary promise, there are still unmet needs that biopharma companies can target to address: GI Tolerability The most common GI adverse events (nausea, vomiting, and diarrhea) often lead to therapy discontinuation

36.2 million people with ESI are potentially eligible for GLP-1 drugs based on an obesity diagnosis alone

Rohmann N, Schlicht K, Geisler C, Hollstein T, Knappe C, Krause L, et al

These principles can guide your counseling and help clients stay well nourished throughout treatment (Mozaffarian, 2025, Gigliotti et al., 2025): Maintain nutritional adequacy Even with smaller portions, clients still need enough calories, protein, and micronutrients to support metabolic health

GLP-1 and GLP-1R additionally have a substantial presence in the brain